StonvexLoading…
StonvexCore line items from OXY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $7.35B | $5.57B | $21.57B | $19.91B | $13.23B |
Operating Income | Not available | $390.00M | $3.13B | $3.24B | $2.07B |
Net Income | Not available | $3.36B | $2.37B | $2.25B | $1.41B |
EPS (Diluted) | $1.83 | $3.13 | $1.61 | $1.68 | $1.03 |
Total Assets | Not available | $80.46B | $84.19B | $83.47B | $84.36B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $3.81B | $1.97B | $2.16B | $2.33B |
Free Cash Flow OCF − CapEx | Not available | $-273.00M | $4.11B | $2.22B | $1.20B |
Shares Outstanding | Not available | 991.19M | 986.03M | 985.18M | 984.42M |